These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 226030)

  • 1. Differentiation of vaccine strains and field isolates of pseudorabies (Aujeszky's disease) virus: thermal sensitivity and rabbit virulence markers.
    Platt KB; Maré CJ; Hinz PN
    Arch Virol; 1979; 60(1):13-23. PubMed ID: 226030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of vaccine strains and field isolates of pseudorabies (Aujeszky's disease) virus: trypsin sensitivity and mouse virulence markers.
    Platt KB; Maré CJ; Hinz PN
    Arch Virol; 1980; 63(2):107-14. PubMed ID: 6243917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aujeszky's disease virus strains with peculiar features.
    Motovski AD
    Acta Vet Hung; 1994; 42(2-3):213-6. PubMed ID: 7810415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of field isolates of suid herpesvirus 1 (Aujeszky's disease virus) as derivatives of attenuated vaccine strains.
    Christensen LS; Medveczky I; Strandbygaard BS; Pejsak Z
    Arch Virol; 1992; 124(3-4):225-34. PubMed ID: 1351387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some characteristics of four attenuated vaccine virus strains and a virulent strain of Aujeszky's disease virus.
    van Oirschot JT; Gielkens AL
    Vet Q; 1984 Sep; 6(4):225-9. PubMed ID: 6093331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Developing an avirulent mutant of Aujeszky's disease virus using the effect of 5 bromodesoxyuridine].
    Tatarov G
    Tijdschr Diergeneeskd; 1983 Mar; 108(5):204-9. PubMed ID: 6302945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
    Gerdts V; Jöns A; Mettenleiter TC
    Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
    Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
    Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease.
    van Oirschot JT; Gielkens AL; Moormann RJ; Berns AJ
    Vet Microbiol; 1990 Jun; 23(1-4):85-101. PubMed ID: 2169682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiation of virulent and attenuated pseudorabies virus strains by biological and genetic markers].
    Golais F; Sabó A
    Dtsch Tierarztl Wochenschr; 1982 Sep; 89(9):377-80. PubMed ID: 6184212
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of virulent and attenuated strains of pseudorabies virus for thymidine kinase activity, virulence and restriction patterns.
    McFarland MD; Hill HT; Tabatabai LB
    Can J Vet Res; 1987 Jul; 51(3):334-9. PubMed ID: 2820560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple defects in the genome of pseudorabies virus can affect virulence without detectably affecting replication in cell culture.
    Lomniczi B; Kaplan AS; Ben-Porat T
    Virology; 1987 Nov; 161(1):181-9. PubMed ID: 2823461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudorabies (Aujeszky's disease) virus: state of the art. August 1993.
    Mettenleiter TC
    Acta Vet Hung; 1994; 42(2-3):153-77. PubMed ID: 7810409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative rates of Aujeszky's disease virus attenuation, as assessed in mice.
    Chong YC; Förster U
    Vet Microbiol; 1987 Nov; 15(3):249-56. PubMed ID: 2829412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of pseudorabies (Aujeszky's disease) virus.
    Mettenleiter TC
    Comp Immunol Microbiol Infect Dis; 1991; 14(2):151-63. PubMed ID: 1657509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies of the virulence of some Aujeszky's disease viral strains].
    Motovski A; Veselinova A; Surtmadzhiev K
    Vet Med Nauki; 1978; 15(1):14-23. PubMed ID: 210561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission.
    Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG
    Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines.
    Peeters B; Bouma A; de Bruin T; Moormann R; Gielkens A; Kimman T
    Vaccine; 1994 Mar; 12(4):375-80. PubMed ID: 8178562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical Aujeszky's disease virus infection in a pig herd and the characterisation of the strain of virus isolated.
    McCullough SJ; Todd D
    Vet Rec; 1988 Jan; 122(4):77-81. PubMed ID: 2832999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.